Although nearly equal amounts of people view the Affordable Care Act favorably (43%) as unfavorably (40%), a majority of Americans say they approved of the Supreme Court's decision to continue to allow Americans living in states on the federally facilitated exchange to be eligible for insurance subsidies, according to a recent poll by the Kaiser Family Foundation.
Although nearly equal amounts of people view the Affordable Care Act favorably (43%) as unfavorably (40%), a majority of Americans say they approved of the Supreme Court's decision to continue to allow Americans living in states on the federally facilitated exchange to be eligible for insurance subsidies, according to a recent poll by the Kaiser Family Foundation.
Only 32% say they disapprove of the ruling, while 62% approve the decision to uphold the use of subsidies on HealthCare.gov. Democrats are more likely to approve the decision and Republicans are more likely to disapprove it, but 29% of Republicans admitted to approving of the ruling.
Support for the decision of the most recent challenge to the ACA is higher than the last Court ruling in 2012, which upheld most of the major provisions of the law. At that time, less than half (47%) approved the ruling and 43% disapproved the decision.
However, despite these findngs, 78% of respondents expect this will not end the debate over Obamacare and expect more major battles on the healthcare law in the future. Only 18% think King v. Burwell will be the last challenge. Nearly half (44%) are tired of hearing about the law and believes the country should move on to other issues, but 51% say it is important to continue the debate.
Read more at Kaiser Family Foundation: http://bit.ly/1dz6Irb
New Research Challenges Assumptions About Hospital-Physician Integration, Medicare Patient Mix
April 22nd 2025On this episode of Managed Care Cast, Brady Post, PhD, lead author of a study published in the April 2025 issue of The American Journal of Managed Care®, challenges the claim that hospital-employed physicians serve a more complex patient mix.
Listen
Personalized Care Key as Tirzepatide Use Expands Rapidly
April 15th 2025Using commercial insurance claims data and the US launch of tirzepatide as their dividing point, John Ostrominski, MD, Harvard Medical School, and his team studied trends in the use of both glucose-lowering and weight-lowering medications, comparing outcomes between adults with and without type 2 diabetes.
Listen
Integrated CKD Care Model Cuts ED Visits by 30%, Boosts Specialized Treatment
April 21st 2025An analysis of an interdisciplinary care model for managing chronic kidney disease (CKD) shows hospital admissions dropped by 26% and emergency department (ED) visits decreased by 30% after clinic initiation.
Read More